Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alkermes plc.ALKS · Entity 2392 | Director | May 20, 2026 | May 23, 2026 |
| CABOT CORPCBT · Entity 4032 | Director | January 08, 2026 | January 12, 2026 |
| NOVANTA INCNOVT · Entity 3857 | Director | January 02, 2026 | January 06, 2026 |
| REVVITY, INC.PKI · Entity 3382 | Please See Remarks | March 05, 2018 | March 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alkermes plc.
Report date May 20, 2026 · Filed May 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 35,751 |
Ending reported balance
After 2026-05-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-21 · Exercise / conversion · Acquired 6,142 · Balance 37,226 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. Row 2 · 2026-05-21 · Tax withholding · Disposed 1,475 · Balance 35,751 |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.98 · Expires 2036-05-20 | Direct | 11,538 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Grant · Acquired 11,538 · Balance 11,538 F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant. |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 5,409 |
Reported balance
After 2026-05-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-20 · Grant · Acquired 5,409 · Balance 5,409 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant. |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-21 · Exercise / conversion · Disposed 6,142 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. F3: This award is fully vested in accordance with its terms. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one ordinary share.
F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant.
F3: This award is fully vested in accordance with its terms.
CABOT CORP
Report date January 08, 2026 · Filed January 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,552 |
Reported balance
After 2026-01-08 transaction · row 1
1 source rowRow 1 · 2026-01-08 · Grant · Acquired 2,298 · Balance 18,552 F1: The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan.
NOVANTA INC
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,947 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Exercise / conversion · Acquired 1,325 · Balance 3,947 F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Exercise / conversion · Disposed 1,325 · Balance 0 F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,799 |
Reported balance
After 2026-01-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-02 · Grant · Acquired 1,799 · Balance 1,799 F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares.
F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).
F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.
REVVITY, INC.
Report date March 05, 2018 · Filed March 06, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,624 |
Reported balance
After 2018-03-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-03-05 · Exercise / conversion · Acquired 31,699 · Balance 93,624 |
| Common StockSEC Table I · non-derivative | Direct | 128,738 |
Reported balance
After 2018-03-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-03-05 · Exercise / conversion · Acquired 35,114 · Balance 128,738 |
| Common StockSEC Table I · non-derivative | Direct | 156,754 |
Reported balance
After 2018-03-05 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2018-03-05 · Exercise / conversion · Acquired 28,016 · Balance 156,754 |
| Common StockSEC Table I · non-derivative | Direct | 165,581 |
Reported balance
After 2018-03-05 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2018-03-05 · Exercise / conversion · Acquired 8,827 · Balance 165,581 |
| Common StockSEC Table I · non-derivative | Direct | 109,654 |
Reported balance
After 2018-03-05 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2018-03-05 · Sale · Disposed 55,627 · Balance 109,654 F1: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018. F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $73.05 to $74.05. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| Common StockSEC Table I · non-derivative | Direct | 61,925 |
Reported balance
After 2018-03-05 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2018-03-05 · Sale · Disposed 48,029 · Balance 61,925 F1: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018. F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $74.06 to $74.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F4: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. |
| NQ Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.01 · Expires 2021-02-21 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-03-05 · Exercise / conversion · Disposed 31,699 · Balance 0 F5: This option became exercisable in three equal annual installments beginning on February 4, 2015, which was the first anniversary of the date on which the option was granted. |
| NQ Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.26 · Expires 2022-02-03 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-03-05 · Exercise / conversion · Disposed 35,114 · Balance 0 F6: This option became exercisable in three equal annual installments beginning on February 3, 2016, which was the first anniversary of the date on which the option was granted. |
| NQ Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.80 · Expires 2023-02-09 | Direct | 14,008 |
Reported balance
After 2018-03-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-03-05 · Exercise / conversion · Disposed 28,016 · Balance 14,008 F7: This option became exercisable in three equal annual installments beginning on February 9, 2017, which was the first anniversary of the date on which the option was granted. |
| NQ Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.65 · Expires 2024-02-07 | Direct | 17,654 |
Reported balance
After 2018-03-05 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-03-05 · Exercise / conversion · Disposed 8,827 · Balance 17,654 F8: This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018.
F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $73.05 to $74.05. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $74.06 to $74.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F4: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account.
F5: This option became exercisable in three equal annual installments beginning on February 4, 2015, which was the first anniversary of the date on which the option was granted.
F6: This option became exercisable in three equal annual installments beginning on February 3, 2016, which was the first anniversary of the date on which the option was granted.
F7: This option became exercisable in three equal annual installments beginning on February 9, 2017, which was the first anniversary of the date on which the option was granted.
F8: This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SPARTON CORP
Report date March 04, 2019 · Filed March 04, 2019
Section 16 reporting ended · disclosed 2019-03-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-04 transaction · row 1
1 source rowRow 1 · 2019-03-04 · Disposition to issuer · Disposed 7,972 · Balance 0 F1: Disposed of pursuant to Agreement and Plan of Merger dated as of December 11, 2018, by and among Sparton Corporation, Sparton Parent, Inc. and Striker Merger Sub 2018, Inc. in exchange for $18.50 per share in cash, without interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to Agreement and Plan of Merger dated as of December 11, 2018, by and among Sparton Corporation, Sparton Parent, Inc. and Striker Merger Sub 2018, Inc. in exchange for $18.50 per share in cash, without interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2017 Filed Feb 8, 2017 22:33 UTC | REVVITY, INC. PKI · Entity 3382 | GrantCommon Stock | 5,797 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-003144 · doc4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,141 F2 · shares: Shares are time-based restricted stock that are scheduled to fully vest on the third anniversary of the date of grant. F3 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 22:33 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 2,841 | $52.17 | $148,214.97 |
DisclosureSEC source: 0000899243-17-003144 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,344 F1 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 4, 2014, as required by the Reporting Person's Restricted Stock Agreement. F3 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| November 10, 2016 Filed Nov 14, 2016 15:58 UTC | SPARTON CORP SPA · Entity 159664 | GrantCommon Stock | 2,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001653528-16-000040 · primary_doc.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,972 F1 · price: This common stock was granted as the reporting person's annual stock grant in consideration of the reporting person's services as a non-employee director of the issuer. The amount of the grant was determined based on the market value of the common stock as of the grant date which was $22.18 per share. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:39 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionNQ Stock Option (right to buy) · Derivative | 46,611 | $0.00 Strike: $21.01 | $0.00 |
DisclosureSEC source: 0000899243-16-029762 · doc4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,611 shares Expires 2017-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option became exercisable in three equal annual installments beginning on February 9, 2011, which was the first anniversary of the date on which the option was granted. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:39 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 46,611 | $55.00 | $2,563,605.00 |
DisclosureSEC source: 0000899243-16-029762 · doc4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,185 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on February 17, 2016 and modified August 11, 2016. F2 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| September 22, 2016 Filed Sep 22, 2016 21:39 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionCommon Stock | 46,611 | $21.01 | $979,297.11 |
DisclosureSEC source: 0000899243-16-029762 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.